Delivery Order SPE2DR25D7909-SPE2DR26FX7EX
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,797.70 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on November 4, 2025, with completion scheduled for November 5, 2025. This firm fixed-price delivery order, processed without a set-aside designation, represents a competitive procurement supporting federal medical supply requirements. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a $1,007.13 delivery order to AmerisourceBergen Drug Corp on December 30, 2025, for M-M-R II vaccine vials. The contract is a firm fixed price delivery order with no set-aside designation, utilizing AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,028.92 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials. The contract is a firm fixed-price delivery order with an ultimate completion date of December 22, 2025, and was awarded on December 19, 2025, without a set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $3,034.01 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on December 19, 2025, with an ultimate completion date of December 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction supporting federal medical supply needs. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,925.33 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials on September 11, 2025. This is a firm fixed price delivery order with an ultimate completion date of September 12, 2025, and represents performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, consistent with AmerisourceBergen's standard federal procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,139.62 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials. This contract employs firm fixed price terms with an ultimate completion date of November 25, 2025, and was awarded competitively without a set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for M-M-R II vaccine vials with a ceiling value of $1,139.62. This competitively awarded, non-set-aside contract utilizes firm fixed price pricing and requires completion by November 28, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for M-M-R II vaccine vials valued at $12,185.58. The contract was competitively awarded with no set-aside designation and employs firm fixed price pricing. The delivery order has an ultimate completion date of July 21, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $12,034.65 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of November 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The contract represents a routine pharmaceutical supply fulfillment under the company's existing relationship with DLA. This delivery order...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,274.16 to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, with an ultimate completion date of November 5, 2025. This firm fixed-price delivery order, issued on November 4, 2025, was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of the company's critical role in supporting...
- SPE2DR25D7909Indefinite Delivery Contract
- SPE2DR25D7909-SPE2DR26FX7EXDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for M-M-R II vaccine vials, valued at $1,242.48, with an award date of December 31, 2025 and ultimate completion date of January 2, 2026. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical vendor, AmerisourceBergen fulfills a broad range of pharmaceutical products and medical supplies to support military healthcare systems and other government agencies. The M-M-R II vaccine delivery under this order supports the company's comprehensive role as a prime vendor for the DLA's global pharmaceutical supply chain serving the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/30/25 |